Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,268 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Teriflunomide/leflunomide synergize with chemotherapeutics by decreasing mitochondrial fragmentation via DRP1 in SCLC.
Mirzapoiazova T, Tseng L, Mambetsariev B, Li H, Lou CH, Pozhitkov A, Ramisetty SK, Nam S, Mambetsariev I, Armstrong B, Malhotra J, Arvanitis L, Nasser MW, Batra SK, Rosen ST, Wheeler DL, Singhal SS, Kulkarni P, Salgia R. Mirzapoiazova T, et al. Among authors: tseng l. iScience. 2024 May 27;27(6):110132. doi: 10.1016/j.isci.2024.110132. eCollection 2024 Jun 21. iScience. 2024. PMID: 38993482 Free PMC article.
An Intraoperative Telemedicine Program to Improve Perioperative Quality Measures: The ACTFAST-3 Randomized Clinical Trial.
King CR, Gregory S, Fritz BA, Budelier TP, Ben Abdallah A, Kronzer A, Helsten DL, Torres B, McKinnon S, Goswami S, Mehta D, Higo O, Kerby P, Henrichs B, Wildes TS, Politi MC, Abraham J, Avidan MS, Kannampallil T; ACTFAST Study Group. King CR, et al. JAMA Netw Open. 2023 Sep 5;6(9):e2332517. doi: 10.1001/jamanetworkopen.2023.32517. JAMA Netw Open. 2023. PMID: 37738052 Free PMC article. Clinical Trial.
Bridging the Two Worlds: Worldwide Reflections on the 2024 Hong Kong SAR/PolyU Conference.
Yeung JW, Bromley A, Chae Y, Cheung DST, Conboy L, Graca S, Levett K, Lumiere K, Schnyer R, Sparrow K, Tseng L, Yoo J, Zhang YQ, Citkovitz C. Yeung JW, et al. Among authors: tseng l. J Integr Complement Med. 2024 Dec;30(12):1125-1129. doi: 10.1089/jicm.2024.0819. Epub 2024 Nov 11. J Integr Complement Med. 2024. PMID: 39527006 No abstract available.
Class I HLA Alleles Are Associated With an Increased Risk of Osimertinib-Induced Hypersensitivity.
Chen CB, Wang CW, Lu CW, Chen WT, Zhou BR, Chu CY, Hsu SF, Yang CT, Wen-Cheng Chang J, Yang CK, Wang CL, Fang YF, Hsu PC, Hua CC, Wu CE, Ko HW, Chen KC, Yang YC, Tseng HC, Cheng AY, Tseng LC, Shih FY, Hung SI, Huang CY, Chung WH. Chen CB, et al. Among authors: tseng lc. J Allergy Clin Immunol Pract. 2025 Jan;13(1):143-154.e10. doi: 10.1016/j.jaip.2024.10.027. Epub 2024 Nov 4. J Allergy Clin Immunol Pract. 2025. PMID: 39505105
Abemaciclib combined with endocrine therapy as adjuvant treatment for hormone-receptor-positive, HER2-, high-risk early breast cancer: 5-year Chinese population analysis of the phase III randomized monarchE study.
Zhang Q, Shen K, Song CG, Ouyang Q, Liu Z, Liu Q, Feng J, Chiu JWY, Tang J, Jiang Z, Tseng LM, Wang X, Yang L, Qian C, Shao Z. Zhang Q, et al. Among authors: tseng lm. Ther Adv Med Oncol. 2024 Oct 23;16:17588359241286775. doi: 10.1177/17588359241286775. eCollection 2024. Ther Adv Med Oncol. 2024. PMID: 39463748 Free PMC article.
1,268 results